International Stem Cell

ISCO · OTC

$0.26−$0.023 (−8.13%)TodayMarket closed · Oct 20, 2:10 PM ET

Prev close $0.283

About ISCO

International Stem Cell Corp. operates as a research and development company for the therapeutic market. The company is headquartered in San Diego, California and currently employs 33 full-time employees. The company went IPO on 2006-09-25. The firm is primarily a research and development company for the therapeutic market, which has focused on advancing potential clinical applications of human parthenogenetic stem cells (hpSCs) for the treatment of various diseases of the central nervous system and liver diseases. The firm's products are based on human cell culture and types of pluripotent stem cells and hpSCs. The firm's subsidiaries include Lifeline Cell Technology, LLC (LCT), which develops, manufactures and commercializes primary human cell research products for the biomedical market; Lifeline Skin Care, Inc. (LSC), which develops, manufactures and markets a category of anti-aging skin care products for anti-aging market, and Cyto Therapeutics Pty. Ltd. (Cyto Therapeutics) performs research and development (R&D) for the therapeutic market.

Employees: 33
Headquarters: San Diego, California
Listed: Sep 25, 2006
Sector: Health Care
Industry: Biotechnology
Website: internationalstemcell.com

Leadership

International Stem Cell executives
Name	Title	Since	Age
Andrey Semechkin	—	—	65
Donald Wright	—	—	73
Russell Kern	—	2008	39
Paul Maier	—	—	77

Revenue by product and region

Fiscal year ended Dec 31, 2025: $9.10M total revenue

By region

United States [Member]$7.84M86.1%
International [Member]$1.24M13.6%

Similar companies

Companies in the same industry as International Stem Cell

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.